Loading...
Loading...
OSMT| Name | Value |
|---|---|
| Revenues | 21.4M |
| Cost of Revenue | 2.1M |
| Gross Profit | 19.3M |
| Operating Expense | 24.7M |
| Operating I/L | -5.4M |
| Other Income/Expense | 0.5M |
| Interest Income | 0.0M |
| Pretax | -6.9M |
| Income Tax Expense | -0.1M |
| Net Income/Loss | -6.8M |
Osmotica Pharmaceuticals plc is an integrated biopharmaceutical company that develops and commercializes a range of pharmaceutical products in the United States, Argentina, and Hungary. The company's promoted products include treatments for attention deficit hyperactivity disorder (ADHD), Parkinson's disease, drug-induced extrapyramidal reactions, multiple sclerosis spasticity, Blepharoptosis, and neurodegenerative disorders. Additionally, it offers women's health products and a variety of non-promoted products for conditions such as major depressive disorders, hypertension, overactive bladder, pain management, and urinary tract infections.
